5th gen glp 1 agonist Frontiers PDB-101: Molecule of the Month:

While Ozempic itself only comes as an injectable, a pill version of semaglutide called Rybelsus is available

thus, they are an attractive therapeutic option for patients with type 2 diabetes, especially those with existing cardiovascular disease or at high risk for those complications

placebo when added to the standard of care [60]

- Decreased cancers could improve the cost-effectiveness calculations on GLP-1 drugs for obesity, although at current high acquisition prices they are still highly unlikely to be cost-saving

Nonetheless, apprehensions persist regarding their elevated expense and the potential exacerbation of healthcare inequities [69, 70]

Complete a health questionnaire